Dragonfly Therapeutics

This early-stage study tested a new drug called DF6215, both alone and combined with an existing immunotherapy (pembrolizumab), in 35 adults with advanced solid tumors that could not be removed by surgery. The main goals were to find a safe dose and check for early signs that the…

This early-stage study tested a new drug called DF6002, both alone and combined with an existing immunotherapy (nivolumab), in patients with advanced solid tumors that had spread or couldn't be removed by surgery. The main goals were to check the safety of different doses and see…

This early-stage study tested a new drug called DF1001 in people with advanced solid tumors that had stopped responding to standard treatments. The main goals were to find a safe dose and see if the drug, given alone or with other cancer therapies, could help shrink tumors. The t…

This was an early-stage study to test a new drug called DF9001 in people with advanced solid tumors that have spread, returned, or cannot be removed by surgery. The main goals were to find a safe dose and see how the body processes the drug. Researchers also looked for early sign…